Cancers · 2020 · 31 citations · 48 references
MedicineCell BiologyOncologyCell DivisionMolecular OncologyTumor ProgressionCancer Cell SignalingCellular AgingCellular SenescenceOvarian CancerTelomere Biology In CancerTelomere MaintenanceCancer Cell SenescenceCell SenescenceCellular Senescence MarkersCyclinsOvarian SenescenceSenescenceSenescence BiologyStat3 Signaling
Spontaneous senescence of cancer cells remains a puzzling and poorly understood phenomenon. Here we comprehensively characterize this process in primary epithelial ovarian cancer cells (pEOCs). Analysis of tumors from ovarian cancer patients showed an abundance of senescent cells in vivo. Further, serially passaged pEOCs become senescent after a few divisions. These senescent cultures display trace proliferation, high expression of senescence biomarkers (SA-β-Gal, γ-H2A.X), growth-arrest in the G1 phase, increased level of cyclins D1, D2, decreased cyclin B1, up-regulated p16, p21, and p53 proteins, eroded telomeres, reduced activity of telomerase, predominantly non-telomeric DNA damage, activated AKT, AP-1, and ERK1/2 signaling, diminished JNK, NF-κB, and STAT3 pathways, increased formation of reactive oxygen species, unchanged activity of antioxidants, increased oxidative damage to DNA and proteins, and dysfunctional mitochondria. Moreover, pEOC senescence is inducible by normal peritoneal mesothelium, fibroblasts, and malignant ascites via the paracrine activity of GRO-1, HGF, and TGF-β1. Collectively, pEOCs undergo spontaneous senescence in a mosaic, telomere-dependent and telomere-independent manner, plausibly in an oxidative stress-dependent mechanism. The process may also be activated by extracellular stimuli. The biological and clinical significance of pEOC senescence remains to be explored.
48
A DNA damage checkpoint response in telomere-initiated senescence
Fabrizio d’Adda di Fagagna, Philip M. Reaper, Lorena Clay-Farrace et al. · Nature · 2003 · 2.8K citations
Senescence in premalignant tumours
Manuel Collado, Jesús Gil, Alejo Efeyan et al. · Nature · 2005 · 1.5K citations
Medicine, Cancer Biology, Oncology +12